Spandan Long Stent Pronova Registry

Pronova Trials

HM Mardikar, NV Deshpande , Aziz Khan - Spandan Heart Institute Nagpur

74 Patients were enrolled in the study.
11(14.8%) had chronic stable angina, 51(68.9%) had unstable angina, 6(8.1%) had prior MI and 6 underwent rescue percutaneous trasluminal angioplasty.
31(41.8 %) were diabetic , 48(64.86%) hypertensive.
85 lesions were treated with 90 long stents.
10 lesions were chronic total occlusion (CTO) , 22 were thrombotic.
49 stents were deployed in left anterior descending lesions (LAD), 25 in right coronary lesions (RCA) and 11 in left circumflex artery lesions (LCX)
48 patients received glycoprotein (Gp) IIb/IIIa inhibitors.
The mean lesion length was 26.2 mm and mean vessel size was 2.96 mm.
Mean stent length was 30.5 mm and mean stent diameter was 3.03 mm.
Seven long lesions were treated with 14 overlapping stents.
Mortality occurred in 1 patient.
69 patients were followed up, 3 underwent coronary artery bypass graft surgery.
All other patients are doing well.

Implantation of Pronova Long length is safe in real world patients.